FDA Workshop on Testing for Malarial Infections in Blood Donors
Acknowledgements
Jerry Holmberg, OPHS, DHHS
Tom McCutchan, NIAID
CDC colleagues
DOD colleagues
AABB members
Jennifer Scharpf, CBER
Rhonda Dawson, CBER
Olga Maximova, CBER
Babita Mahajan, CBER
David Asher, CBER
Program committee members
Presentations
- FDA Workshop on Testing for Malarial Infections in Blood Donors - Hira Nakhasi, Ph.D.
- Global Problem of Malaria, Biology of Malaria Parasites and Implications for Transfusion-Transmitted Malaria and Detection Methods - Sanjai Kumar, Ph.D.
- Current Deferral Policies to Reduce the Risk of Transfusion-Transmitted Malaria and their Impact on Donor Availability - Alan E. Williams
- UK experience regarding malaria antibody tests and their contribution to blood safety - Professor PL Chiodini
- Malaria in the United States military and its implications for the safety of the blood supply? - Christian F. Ockenhouse M.D., Ph.D.
- Enhancing US Blood Availability by Testing for Plasmodium spp. Infection - David A. Leiby, PhD
- Antigen/Antibody Detection Assays for Malaria - Freddie M. Poole
- CDC Experience with Laboratory Tests Used to Investigate Incidents of Transfusion-Transmitted Malaria - Marianna Wilson
- Traveler's malaria, locally-transmitted malaria, and transfusion-transmitted malaria in the United States - Monica E. Parise, MD
- Malaria antibody test development - Nigel Appleton
- Malaria donor deferral policy in France: French experience with malaria antibody screening - Olivier GARRAUD; Marie-Hélène ELGHOUZZI; Azzedine ASSAL; Bertrand PELLETIER; Josiane RELAVE; Georges ANDREU
- Prospects for DNA-Based Tests to Detect Malaria Infections - Sanjai Kumar, Ph.D.
- Risks versus benefits related to the possible implementation of a malaria blood-screening test - Steve Anderson
- Issues with Malaria Screening in the US - Susan L. Stramer, Ph.D.